MITO | Stealth BioTherapeutics
Quick infos Headquarters: Cayman Islands Trade prices Volume: Market Cap: 14.99M Prev closed: 2.15 Open: 2.1 High: 2.14 Low: 2 52 week low: 0.9 52 week high: 5 Dividends: No Dividends Next ER: May 17, 2022
Company Profile We are an innovative biopharmaceutical company developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.
Earnings History Date EPS / Forecast Revenue / Forecast August 17, 2022 May 18, 2022 - / -0.02- / -April 6, 2022 -0.025 / -0.11- / -November 11, 2021 -0.01 / -0.02- / -August 5, 2021 -0.03 / -0.02- / -view more
Historical Data Date Price Open High Low Vol Change ER May 16, 2022 0.2432 0.2270 0.2500
0.2000
1.92M 7.71% May 13, 2022 0.2258 0.2300 0.2301
0.1899
5.39M -9.68% May 12, 2022 0.2500 0.3259 0.3790
0.2140
76.41M 31.51% May 11, 2022 0.1901 0.2169 0.2199
0.1820
1.57M -11.58% May 10, 2022 0.2150 0.2300 0.2950
0.2000
4.08M -5.29% May 9, 2022 0.2270 0.1925 0.2348
0.1776
4.27M 24.38% May 6, 2022 0.1825 0.2100 0.2250
0.1745
5.51M -13.05% May 5, 2022 0.2099 0.2728 0.2747
0.2096
2.99M -21.39% May 4, 2022 0.2670 0.2900 0.3050
0.2550
2.80M -9.43% May 3, 2022 0.2948 0.2701 0.3450
0.2701
4.36M 6.04% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Stealth BioTherapeutics EPS misses by $0.08 seekingalpha.com Apr 6, 2021 7:48 pm Stealth Biotherapeutics promotes Marty Redmon to chief research & development officer seekingalpha.com Mar 16, 2021 7:43 pm Is it Time to Dump Stealth BioTherapeutics Corp (MITO) Stock After it Has Gained 9.33% in a Week? investorsobserver.com Feb 17, 2021 8:56 am Where Does Stealth BioTherapeutics Corp (MITO) Stock Fall in the Biotechnology Field? investorsobserver.com Feb 12, 2021 8:56 am Should Stealth BioTherapeutics Corp (MITO) Stock Be in Your Portfolio? investorsobserver.com Feb 11, 2021 8:56 am Stealth Bio drops 7% on capital raise via direct offering seekingalpha.com Feb 10, 2021 9:04 pm
Stealth BioTherapeutics Announces Pricing Of $4.7 Million Registered Direct Offering Of American Depositary Shares finance.yahoo.com Feb 10, 2021 7:54 am
The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping finance.yahoo.com Jan 6, 2021 7:30 am
Stealth BioTherapeutics Announces Elamipretide Clinical Data to be Presented at the 13th International Conference on Cachexia, Sarcopenia and Wasting Diseases finance.yahoo.com Dec 9, 2020 4:30 pm Stealth BioTherapeutics Corp (MITO) Q3 2020 Earnings Call Transcript fool.com Nov 6, 2020 9:31 pm Is Stealth BioTherapeutics Corp (MITO) the Top Pick in the Biotechnology Industry? investorsobserver.com Feb 11, 2021 8:56 am Stealth BioTherapeutics Corp (MITO) Stock: What Does the Chart Say? investorsobserver.com Feb 11, 2021 8:56 am Is Stealth BioTherapeutics Corp (MITO) Stock Near the Top of the Biotechnology Industry? investorsobserver.com Jan 21, 2021 8:56 am Should You Buy Stealth BioTherapeutics Corp (MITO) Stock on Thursday? investorsobserver.com Jan 21, 2021 8:56 am FDA accepts Stealth Bio's Pre-NDA meeting request for elamipretide seekingalpha.com Jan 6, 2021 8:19 pm Is Stealth BioTherapeutics Corp (MITO) A Good Stock To Buy? finance.yahoo.com Nov 29, 2020
Reflecting on Stealth BioTherapeutics' (NASDAQ:MITO) Share Price Returns Over The Last Year finance.yahoo.com Nov 22, 2020 3:45 am Stealth Bio launches $3.2M registered direct offering seekingalpha.com Nov 20, 2020 9:07 pm This company doesn't provide a dividend.
Talk about Stealth BioTherapeutics below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
